-+ 0.00%
-+ 0.00%
-+ 0.00%

Camp4 Therapeutics Q1 EPS $(0.62) Up From $(26.57) YoY, Sales $858.00K

Benzinga·05/13/2025 20:34:18
Listen to the news
Camp4 Therapeutics (NASDAQ:CAMP) reported quarterly losses of $(0.62) per share. This is a 97.67 percent increase over losses of $(26.57) per share from the same period last year. The company reported $858.00 thousand in sales this quarter.